Carbapenemase Gene Dynamics in CREC: Insights from Guangdong
2026-05-07
This study systematically characterizes carbapenemase-encoding genes (CEGs) and their transmission in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals during the COVID-19 pandemic. The findings advance understanding of CEG prevalence, transferability, and epidemiology, with critical implications for antibacterial resistance surveillance and experimental infection modeling.
Caspase-3 Cleavage of NDUFS1 Drives Trichothecene-Induced Mi
2026-05-07
This study reveals that trichothecene mycotoxins induce hepatotoxicity via a caspase-3/NDUFS1 axis, leading to mitochondrial dysfunction and ROS accumulation. The work identifies a positive feedback loop between mitochondrial and ER-derived ROS, highlighting mechanistic targets for mitigating oxidative stress in toxin-exposed livers.
Rotavirus Suppresses Nrf2-Driven Redox Defense: Mechanistic
2026-05-06
This study reveals how progressive rotavirus infection actively downregulates the redox-sensitive transcription factor Nrf2 and its downstream antioxidant gene network in host cells. The findings clarify distinct temporal regulation of Nrf2, highlight proteasomal degradation as a key suppression mechanism, and suggest new avenues for therapeutic intervention in oxidative stress during viral infection.
Verbascoside (B3379): Advancing PKC/NF-κB Pathway Research
2026-05-06
Explore how Verbascoside, a potent PKC/NF-κB inhibitor, uniquely enables mechanistic and translational studies of inflammatory signaling and osteoclastogenesis. This analysis highlights new insights from recent molecular neurobiology research and expert protocols.
Reversine: Aurora Kinase Inhibitor Workflows for Cancer Rese
2026-05-05
Reversine is a powerful Aurora kinase inhibitor that enables precise control of mitotic checkpoints and apoptosis induction in cancer models. This guide delivers actionable protocols, advanced applications, and troubleshooting strategies to maximize experimental success using Reversine from APExBIO.
Golgi-Tracker Green: Illuminating Golgi Stress and Membrane
2026-05-05
Explore how Golgi-Tracker Green, a BODIPY FL-labeled C5-ceramide probe, empowers high-resolution visualization of Golgi apparatus stress and membrane remodeling in live cells. Discover its unique scientific value and assay optimization insights distinct from standard workflow articles.
Foretinib (GSK1363089): Precision Modulation of Tumor Cell D
2026-05-04
Explore how Foretinib (GSK1363089) enables precise modulation of tumor cell growth and motility in advanced cancer research. This article highlights the compound’s nuanced action, interprets key in vitro evaluation insights, and offers practical assay guidance beyond standard workflows.
UBE2F-SAG-Mediated RHEB Neddylation Drives mTORC1 in Liver C
2026-05-04
This study identifies RHEB as a direct substrate for neddylation by the UBE2F-SAG E2/E3 ligase complex, establishing a new regulatory axis that enhances mTORC1 activity and promotes liver tumorigenesis. The findings clarify the mechanistic link between post-translational modification of RHEB and aberrant mTORC1 signaling in hepatocellular carcinoma, offering new avenues for targeted intervention.
IRG1–Itaconic Acid Axis Regulates Interferon by TBK1 Alkylat
2026-05-03
Chai et al. uncover how the metabolic enzyme IRG1 and its product itaconic acid exert feedback inhibition on type I interferon signaling by alkylating TBK1, disrupting its dimerization and downstream activation. This mechanism links metabolic state to immune modulation and highlights new avenues for therapeutic control of hyperinflammatory responses.
Ruxolitinib (INCB018424): Advanced Workflows in Myeloprolife
2026-05-02
Ruxolitinib (INCB018424) is a selective JAK1/2 inhibitor that empowers researchers to dissect and modulate JAK-STAT signaling in myeloproliferative and oncogenic JAK2 fusion protein models. Discover protocol enhancements, spectral cytometry innovations, and troubleshooting strategies informed by cutting-edge translational research.
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine:
2026-05-02
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine empowers advanced α2-adrenergic receptor agonist workflows in immune rejection modulation and post-surgery osteosarcoma research. Its high purity and robust DMSO solubility enable reproducible, cutting-edge assay design in G protein-coupled receptor studies.
Glucocorticoid Receptor Modulation of CYPs and Neuroprotecti
2026-05-01
This study reveals that pregnenolone 16α-carbonitrile (PCN) attenuates phenytoin-induced neurotoxicity by downregulating hippocampal cytochrome P450 (CYP) enzymes via a glucocorticoid receptor-dependent, PXR-independent mechanism. These findings highlight a novel neuroprotective pathway and suggest broader implications for modulating CYP-mediated neurosteroid metabolism in the central nervous system.
Patient-Derived Gastric Cancer Assembloids Enhance Drug Mode
2026-04-30
This study introduces a patient-derived gastric cancer assembloid system that integrates matched tumor organoids and autologous stromal cell subpopulations, more accurately recapitulating the native tumor microenvironment. The model reveals how stromal heterogeneity drives gene expression and modulates drug sensitivity, providing an advanced platform for studying resistance mechanisms and developing personalized therapies.
Cefiderocol vs. Ceftolozane: In Vitro Activity Against Resis
2026-04-30
This study systematically compared cefiderocol and several β-lactam/β-lactamase inhibitor combinations, including ceftolozane-tazobactam, for their in vitro activity against European Pseudomonas aeruginosa and Acinetobacter spp. isolates. Its findings refine the clinical and experimental landscape for managing multidrug-resistant non-fermenters and inform assay development and antibacterial strategy selection.
Bradykinin (BA5201): Technical Guide for Vasodilation Resear
2026-04-29
Bradykinin (SKU BA5201) is a validated endothelium-dependent vasodilator peptide enabling reproducible studies of vascular tone, permeability, and inflammation signaling. This guide details its optimal use in mechanistic assays and highlights protocol parameters, troubleshooting, and QC best practices. Bradykinin is unsuitable for diagnostic or clinical use; it is strictly for controlled laboratory workflows.
512 records 23/35 page Previous Next First page 上5页 2122232425 下5页 Last page